Stage III Non-Small Cell Lung Cancer AJCC v7 Terminated Phase 1 Trials for Atezolizumab (DB11595)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03455556Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung CancerTreatment